Stranger than fiction.

They want to be rewarded for sacrifices they made when the airline was ailing three years ago.

The group votes to further restrict Amgen’s Aranesp and J&J’s Procrit, but doesn’t entirely bar their use.

The credit crunch clobbers shares.

Genesco gains on earnings and a new stock-buyback plan.

Sigma Designs gets hammered.

The fourth-quarter results miss analysts estimates.

Crude tops $111-a-barrel before ending little changed.

Bear Stearns is falling.

Yahoo! may be running out of white knights to save it from a Microsoft buyout.

Take-Two’s shareholders may be receptive to EA’s tender offer.